Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Logo for

Science 340 (6129): 202-207

Copyright © 2013 by the American Association for the Advancement of Science

Blockade of Chronic Type I Interferon Signaling to Control Persistent LCMV Infection

Elizabeth B. Wilson,1 Douglas H. Yamada,1 Heidi Elsaesser,1 Jonathan Herskovitz,1 Jane Deng,2 Genhong Cheng,1 Bruce J. Aronow,3 Christopher L. Karp,4,* David G. Brooks1,{dagger}

Abstract: Type I interferons (IFN-I) are critical for antiviral immunity; however, chronic IFN-I signaling is associated with hyperimmune activation and disease progression in persistent infections. We demonstrated in mice that blockade of IFN-I signaling diminished chronic immune activation and immune suppression, restored lymphoid tissue architecture, and increased immune parameters associated with control of virus replication, ultimately facilitating clearance of the persistent infection. The accelerated control of persistent infection induced by blocking IFN-I signaling required CD4 T cells and was associated with enhanced IFN-{gamma} production. Thus, we demonstrated that interfering with chronic IFN-I signaling during persistent infection redirects the immune environment to enable control of infection.

1 Department of Microbiology, Immunology and Molecular Genetics and the UCLA AIDS Institute, David Geffen School of Medicine, University of California, Los Angeles (UCLA), Los Angeles, CA 90095, USA.
2 Division of Pulmonary and Critical Care Medicine, David Geffen School of Medicine, UCLA, Los Angeles, CA 90095, USA.
3 Division of Biomedical Informatics and Division of Developmental Biology, Cincinnati Children’s Hospital Research Foundation and the University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
4 Division of Molecular Immunology, Cincinnati Children’s Hospital Research Foundation and the University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.

* Present address: The Bill and Melinda Gates Foundation, Seattle, WA 98109, USA.

{dagger} Corresponding author. E-mail: dbrooks{at}

IFN-{lambda} Exerts Opposing Effects on T Cell Responses Depending on the Chronicity of the Virus Infection.
I. Misumi and J. K. Whitmire (2014)
J. Immunol. 192, 3596-3606
   Abstract »    Full Text »    PDF »
Type I interferons directly inhibit regulatory T cells to allow optimal antiviral T cell responses during acute LCMV infection.
S. Srivastava, M. A. Koch, M. Pepper, and D. J. Campbell (2014)
J. Exp. Med.
   Abstract »    Full Text »    PDF »
Immune Cells Link Obesity-associated Type 2 Diabetes and Periodontitis.
M. Zhu and B. S. Nikolajczyk (2014)
Journal of Dental Research 93, 346-352
   Abstract »    Full Text »    PDF »
Enhanced Innate Antiviral Gene Expression, IFN-{alpha}, and Cytolytic Responses Are Predictive of Mucosal Immune Recovery during Simian Immunodeficiency Virus Infection.
D. Verhoeven, M. D. George, W. Hu, A. T. Dang, Z. Smit-McBride, E. Reay, M. Macal, A. Fenton, S. Sankaran-Walters, and S. Dandekar (2014)
J. Immunol. 192, 3308-3318
   Abstract »    Full Text »    PDF »
Pharmacological Inhibition of Type I Interferon Signaling Protects Mice Against Lethal Sepsis.
L. Dejager, S. Vandevyver, M. Ballegeer, E. Van Wonterghem, L.-L. An, J. Riggs, R. Kolbeck, and C. Libert (2014)
The Journal of Infectious Disease 209, 960-970
   Abstract »    Full Text »    PDF »
Type I IFN Induces Binding of STAT1 to Bcl6: Divergent Roles of STAT Family Transcription Factors in the T Follicular Helper Cell Genetic Program.
S. Nakayamada, A. C. Poholek, K. T. Lu, H. Takahashi, M. Kato, S. Iwata, K. Hirahara, J. L. Cannons, P. L. Schwartzberg, G. Vahedi, et al. (2014)
J. Immunol. 192, 2156-2166
   Abstract »    Full Text »    PDF »
Therapeutic Depletion of Natural Killer Cells Controls Persistent Infection.
S. N. Waggoner, K. A. Daniels, and R. M. Welsh (2014)
J. Virol. 88, 1953-1960
   Abstract »    Full Text »    PDF »
Strain-specific innate immune signaling pathways determine malaria parasitemia dynamics and host mortality.
J. Wu, L. Tian, X. Yu, S. Pattaradilokrat, J. Li, M. Wang, W. Yu, Y. Qi, A. E. Zeituni, S. C. Nair, et al. (2014)
PNAS 111, E511-E520
   Abstract »    Full Text »    PDF »
Effects of Alpha Interferon Treatment on Intrinsic Anti-HIV-1 Immunity In Vivo.
M. Abdel-Mohsen, X. Deng, T. Liegler, J. C. Guatelli, M. S. Salama, H. E.-d. A. Ghanem, A. Rauch, B. Ledergerber, S. G. Deeks, H. F. Gunthard, et al. (2014)
J. Virol. 88, 763-767
   Abstract »    Full Text »    PDF »
Confounding roles for type I interferons during bacterial and viral pathogenesis.
J. A. Carrero (2013)
Int. Immunol. 25, 663-669
   Abstract »    Full Text »    PDF »
Virus-associated activation of innate immunity induces rapid disruption of Peyer's patches in mice.
S. Heidegger, D. Anz, N. Stephan, B. Bohn, T. Herbst, W. P. Fendler, N. Suhartha, N. Sandholzer, S. Kobold, C. Hotz, et al. (2013)
Blood 122, 2591-2599
   Abstract »    Full Text »    PDF »
IFN-{alpha} Inhibits Telomerase in Human CD8+ T Cells by Both hTERT Downregulation and Induction of p38 MAPK Signaling.
A. Lanna, E. Coutavas, L. Levati, J. Seidel, M. H. A. Rustin, S. M. Henson, A. N. Akbar, and O. Franzese (2013)
J. Immunol. 191, 3744-3752
   Abstract »    Full Text »    PDF »
An Interferon Paradox.
P. M. Odorizzi and E. J. Wherry (2013)
Science 340, 155-156
   Abstract »    Full Text »    PDF »

To Advertise     Find Products

Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882